Login / Signup

Pevonedistat with azacitidine in older patients with TP53-mutated AML: a phase 2 study with laboratory correlates.

Antoine N SalibaScott H KaufmannEytan M SteinPrapti Arvind PatelMaria R BaerWendy StockMichael W DeiningerWilliam BlumGary J SchillerRebecca L OlinMark R LitzowTara L LinBrian John BallMichael BoyiadzisJennifer DunlapOlatoyosi OdenikeMartha L ArellanoAlison R WalkerVu H DuongTibor J KovacsovicsRobert H CollinsAbigail B ShobenNyla A HeeremaMatthew C FosterKevin L PetersonPaula A SchneiderMolly MartyczTheophilus GanaLeonard RosenbergSonja MarcusAshley O YocumTimothy L ChenMona StefanosAlice S MimsUma BorateAmy BurdBrian J DrukerRoss L LevineJohn C ByrdJames M Foran
Published in: Blood advances (2022)
Keyphrases
  • acute myeloid leukemia
  • open label
  • community dwelling
  • allogeneic hematopoietic stem cell transplantation
  • middle aged
  • physical activity
  • double blind
  • placebo controlled
  • clinical trial
  • acute lymphoblastic leukemia